QT
FPRX

Quantbot Technologies’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Quantbot Technologies’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-7,620
Closed -$106K – 1570
2018
Q3 		$106K Sell
7,620
-2,810
-27% -$41.8K 0.01% 865
2018
Q2 		$164K Buy
10,430
+3,083
+42% +$53.8K 0.01% 772
2018
Q1 		$126K Buy
7,347
+5,755
+361% +$112K 0.01% 793
2017
Q4 		$34K Buy
1,592
+1,372
+624% +$44.1K ﹤0.01% 1023
2017
Q3 		$9K Sell
220
-2,759
-93% -$86.6K ﹤0.01% 1098
2017
Q2 		$89K Buy
2,979
+1,556
+109% +$48.6K 0.01% 824
2017
Q1 		$51K Buy
+1,423
New +$62.7K 0.01% 911
2016
Q1 		– Sell
-33
Closed -$1K – 1495
2015
Q4 		$1K Sell
33
-2,923
-99% -$98K ﹤0.01% 1035
2015
Q3 		$45K Buy
+2,956
New +$63.5K 0.01% 933
2015
Q2 		– Sell
-3,674
Closed -$83K – 1456
2015
Q1 		$83K Buy
+3,674
New +$92.7K 0.02% 662

Other funds holding FPRX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Quantbot Technologies's FPRX Position: Q4 2018 in Review

Quantbot Technologies sold out of Five Prime Therapeutics, Inc. (FPRX) in Q4 2018, closing a stake of 7,620 shares — an estimated $106K sold.

Quantbot Technologies first reported a position in FPRX in Q1 2015 and held it in 10 quarters. The position peaked at $164K in Q2 2018. 116 funds tracked by Wall St. Rank hold FPRX as of Q4 2018.

  • Quantbot Technologies reported no remaining Five Prime Therapeutics, Inc. position as of Q4 2018 after selling out during the quarter.
  • Quantbot Technologies sold 7,620 Five Prime Therapeutics, Inc. shares in Q4 2018, an estimated $106K.
  • Quantbot Technologies first reported a position in Five Prime Therapeutics, Inc. in Q1 2015 and held it in 10 quarters.
  • Quantbot Technologies's Five Prime Therapeutics, Inc. position peaked at $164K in Q2 2018.
  • 116 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q4 2018.

Based on Quantbot Technologies's 13F filing for Q4 2018, filed 13 Feb 2019.